These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 15242682

  • 1. Bisphosphonates: new therapeutic agents for the treatment of bone tumors.
    Heymann D, Ory B, Gouin F, Green JR, Rédini F.
    Trends Mol Med; 2004 Jul; 10(7):337-43. PubMed ID: 15242682
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonate actions on cancer.
    Yoneda T, Hashimoto N, Hiraga T.
    Calcif Tissue Int; 2003 Oct; 73(4):315-8. PubMed ID: 12874704
    [Abstract] [Full Text] [Related]

  • 3. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D, Henschke P, Possinger K.
    Anticancer Res; 2007 Oct; 27(4A):1759-68. PubMed ID: 17649770
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of bisphosphonates.
    Green JR.
    Cancer; 2003 Feb 01; 97(3 Suppl):840-7. PubMed ID: 12548584
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The crossover of bisphosphonates to cancer therapy.
    Sun M, Iqbal J, Singh S, Sun L, Zaidi M.
    Ann N Y Acad Sci; 2010 Nov 01; 1211():107-12. PubMed ID: 21062299
    [Abstract] [Full Text] [Related]

  • 9. The antitumor potential of bisphosphonates.
    Clézardin P.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
    Li J, Rugo HS.
    Breast Dis; 2011 Dec 01; 33(2):83-92. PubMed ID: 22142661
    [Abstract] [Full Text] [Related]

  • 11. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
    Lipton A.
    J Support Oncol; 2004 Dec 01; 2(3):205-13; discussion 213-4, 216-7, 219-20. PubMed ID: 15328823
    [Abstract] [Full Text] [Related]

  • 12. The critical role of bisphosphonates to target bone cancer metastasis: an overview.
    Singh T, Kaur V, Kumar M, Kaur P, Murthy RS, Rawal RK.
    J Drug Target; 2015 Jan 01; 23(1):1-15. PubMed ID: 25203856
    [Abstract] [Full Text] [Related]

  • 13. Moving into the future: treatment of bone metastases and beyond.
    Hortobagyi GN.
    Cancer Treat Rev; 2005 Jan 01; 31 Suppl 3():9-18. PubMed ID: 16249057
    [Abstract] [Full Text] [Related]

  • 14. Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates.
    Green JR.
    Acta Oncol; 2005 Jan 01; 44(3):282-92. PubMed ID: 16076701
    [Abstract] [Full Text] [Related]

  • 15. Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.
    Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T.
    Cancer Treat Rev; 1999 Oct 01; 25(5):293-9. PubMed ID: 10544073
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonates: preclinical review.
    Green JR.
    Oncologist; 2004 Oct 01; 9 Suppl 4():3-13. PubMed ID: 15459425
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?
    Freedman OC, Amir E, Clemons MJ.
    Crit Rev Oncol Hematol; 2009 Oct 01; 72(1):56-64. PubMed ID: 19307138
    [Abstract] [Full Text] [Related]

  • 18. [Antitumour effects of bisphosphonates in breast cancer].
    van de Ven S, Kroep JR, Hamdy NA, Sleeboom HP, Nortier HW.
    Ned Tijdschr Geneeskd; 2010 Oct 01; 154():A1951. PubMed ID: 21083955
    [Abstract] [Full Text] [Related]

  • 19. New results from the use of bisphosphonates in cancer patients.
    Coleman R, Gnant M.
    Curr Opin Support Palliat Care; 2009 Sep 01; 3(3):213-8. PubMed ID: 19561507
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.